Volume 27, Number 11—November 2021
Research
Seroprevalence of SARS-CoV-2–Specific Antibodies among Quarantined Close Contacts of COVID-19 Patients, Faroe Islands, 2020
Table 2
Age, y | Total no. contacts | Had symptoms in quarantine | RT-PCR conducted | Mean days from start of quarantine to first RT-PCR (SD) | Median days from start of quarantine to first RT-PCR (range) |
---|---|---|---|---|---|
0–9 | 8 | 6 (75.0) | 8 (100.0)† | 5.5 (5.5) | 6.0 (0–15) |
10–17 | 6 | 0 | 4 (66.7) | 7.0 (4.8) | 8.5 (0–11) |
18–34 | 9 | 5 (55.6) | 3 (33.3)‡ | 0.3 (0.6) | 0 (0–1) |
35–49 | 3 | 1 (33.3) | 3 (100.0)§ | 0.7 (2.1) | 0 (–1 to 3) |
50–66 | 2 | 1 (50.0) | 1 (50.0) | 0 | 0 |
>67 | 4 | 1 (25.0) | 2 (50.0) | 0 | 0 |
*Values are no. (%) except as indicated. RT-PCR, reverse transcription PCR; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2. †Three contacts had 2 RT-PCRs. ‡One contact had 2 RT-PCRs and 1 had 4 RT-PCRs. §One contact had 2 RT-PCRs.
Page created: August 06, 2021
Page updated: October 19, 2021
Page reviewed: October 19, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.